Sanofi announced that the Food and Drug Administration (FDA) has approved Toujeo (insulin glargine 300 Units/mL) Max SoloStar, a long-acting insulin pen that holds 900 Units of Toujeo and provides up ...
If you have type 1 or type 2 diabetes, your doctor might prescribe Toujeo. It’s a prescription diabetes medication used in adults and some children. To learn more about diabetes and how Toujeo is used ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
Glooko Inc. announced that the company have entered into a partnering agreement with Sanofi to increase their support of people living with diabetes and healthcare professionals, by integrating ...
On February 14, 2025, the FDA approved Sanofi’s Merilog™ / Merilog SoloStar ® (insulin aspart-szjj), the first biosimilar of Novo Nordisk’s NovoLog ® (insulin aspart). Merilog™ is packaged in a ...
Sanofi lost its appeals court bid to revive patents on its blockbuster Lantus SoloStar insulin injection pen in a victory for drugmaker Viatris Inc. A review board was correct to invalidate five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results